Arjuna (Vrcholiak arjuna) – Terminalia arjuna

Literatúra

  1. Raj CD, et al. Terminalia arjuna’s antioxidant effect in isolated perfused kidney. Res Pharm Sci. (2012)
  2. Dwivedi S. Terminalia arjuna Wight & Arn.–a useful drug for cardiovascular disorders. J Ethnopharmacol. (2007)
  3. Mahmood ZA, et al. Herbal treatment for cardiovascular disease the evidence based therapy. Pak J Pharm Sci. (2010)
  4. Maulik SK, Katiyar CK. Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Curr Pharm Biotechnol. (2010)
  5. Miller AL. Botanical influences on cardiovascular disease. Altern Med Rev. (1998)
  6. Scassellati-Sforzolini G, et al. Antigenotoxic properties of Terminalia arjuna bark extracts. J Environ Pathol Toxicol Oncol. (1999)
  7. Verma SC, et al. Microwave extraction and rapid isolation of arjunic acid from Terminalia arjuna (Roxb. ex DC.) stem bark and quantification of arjunic acid and arjunolic acid using HPLC-PDA technique. J Sep Sci. (2012)
  8. Sarwat M, Das S, Srivastava PS. Estimation of genetic diversity and evaluation of relatedness through molecular markers among medicinally important trees: Terminalia arjuna, T. chebula and T. bellerica. Mol Biol Rep. (2011)
  9. Biswas M, et al. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice. Nat Prod Res. (2012)
  10. [No authors listed. Terminalia arjuna. Altern Med Rev. (1999)
  11. The chemistry of extractives from hardwoods. Part XVIII. The constitution of arjunolic acid, a triterpene from Terminalia arjuna.
  12. Saxena M, et al. Cytotoxic agents from Terminalia arjuna. Planta Med. (2007)
  13. Singh DV, et al. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. (2002)
  14. Wang W, et al. 18,19-secooleanane type triterpene glycosyl esters from the bark of Terminalia arjuna. Planta Med. (2010)
  15. Upadhyay RK, et al. Triterpene glycoside from Terminalia arjuna. J Asian Nat Prod Res. (2001)
  16. Wang W, et al. Triterpenoids from two Terminalia species. Planta Med. (2010)
  17. Ali A, et al. A novel naphthanol glycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie. (2003)
  18. Alam MS, et al. Two new bioactive oleanane triterpene glycosides from Terminalia arjuna. Nat Prod Res. (2008)
  19. Ali A, et al. Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J Asian Nat Prod Res. (2003)
  20. Singh B, et al. A new triterpene glycoside from Terminalia arjuna. Planta Med. (1995)
  21. Dwivedi S, Aggarwal A. Indigenous drugs in ischemic heart disease in patients with diabetes. J Altern Complement Med. (2009)
  22. Yadav RN, Rathore K. A new cardenolide from the roots of Terminalia arjuna. Fitoterapia. (2001)
  23. Yadava RN, Rathore K. A new cardenolide from the seeds of Terminalia arjuna (W&A). J Asian Nat Prod Res. (2000)
  24. Wang W, et al. Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia. (2010)
  25. Oberoi L, et al. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine. (2011)
  26. Kuo PL, et al. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7 cells. Planta Med. (2005)
  27. Kandil FE, Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. (1998)
  28. Avula B, et al. Simultaneous Determination and Characterization of Tannins and Triterpene Saponins from the Fruits of Various Species of Terminalia and Phyllantus emblica Using a UHPLC-UV-MS Method: Application to Triphala. Planta Med. (2013)
  29. Khaliq F, et al. Terminalia arjuna Improves Cardiovascular Autonomic Neuropathy in Streptozotocin-Induced Diabetic Rats. Cardiovasc Toxicol. (2013)
  30. Dall’Ago P, et al. Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res. (1997)
  31. Parveen A, et al. Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats. J Cardiovasc Pharmacol Ther. (2012)
  32. Parveen A, et al. Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovasc Toxicol. (2011)
  33. Kumar S, et al. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J Pharm Pharmacol. (2009)
  34. Sinha M, Manna P, Sil PC. Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress. J Med Food. (2008)
  35. Singh G, et al. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J Ethnopharmacol. (2008)
  36. Karthikeyan K, et al. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci. (2003)
  37. Gauthaman K, et al. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein. J Ethnopharmacol. (2005)
  38. Manna P, Sinha M, Sil PC. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology. (2007)
  39. Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. (1997)
  40. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med. (1992)
  41. Ischemic mitral regurgitation: mechanisms and echocardiographic classification.
  42. Dwivedi S, et al. Role of Terminalia arjuna in ischaemic mitral regurgitation. Int J Cardiol. (2005)
  43. Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol. (1995)
  44. Bharani A, et al. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. (2002)
  45. Dwivedi S, Kumar V. Beta-thalassemia, hyperlipoproteinemia(a), and metabolic syndrome: its low-cost holistic therapy. J Altern Complement Med. (2007)
  46. Subramaniam S, et al. Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. Evid Based Complement Alternat Med. (2011)
  47. Subramaniam S, et al. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol. (2011)
  48. Johnston TP, Palmer WK. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol. (1993)
  49. Chander R, et al. Antidyslipidemic and antioxidant activities of different fractions ofTerminalia arjuna stem bark. Indian J Clin Biochem. (2004)
  50. Bharani A, Ahirwar LK, Jain N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J. (2004)
  51. Saha S, Verma R. Inhibitory potential of traditional herbs on α-amylase activity. Pharm Biol. (2012)
  52. Biswas M, et al. Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol. (2011)
  53. Sandhu JS, et al. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Ayurveda Res. (2010)
  54. Parmar HS, et al. Cardio-protective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie. (2006)
  55. Watanabe H, et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun. (2003)
  56. Donatelli M, et al. Cardiac changes in subclinical and overt hyperthyroid women: retrospective study. Int J Cardiol. (2003)
  57. Devi RS, et al. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. J Pharm Pharmacol. (2008)
  58. Devi RS, et al. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytother Res. (2007)
  59. Devi RS, et al. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chem Biol Interact. (2007)
  60. Aneja KR, Sharma C, Joshi R. Antimicrobial activity of Terminalia arjuna Wight & Arn.: an ethnomedicinal plant against pathogens causing ear infection. Braz J Otorhinolaryngol. (2012)
  61. Shivananjappa MM, Mhasavade D, Joshi MK. Aqueous extract of Terminalia arjuna attenuates tert-butyl hydroperoxide-induced oxidative stress in HepG2 cell model. Cell Biochem Funct. (2012)
  62. Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complement Altern Med. (2006)
  63. Ragavan B, Krishnakumari S. Effect of terminalia arjuna stem bark extract on the activities of marker enzymes in alloxan induced diabetic rats. Anc Sci Life. (2005)
  64. Raghavan B, Kumari SK. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats. Indian J Physiol Pharmacol. (2006)
  65. Chen CH, et al. Casuarinin protects cultured MDCK cells from hydrogen peroxide-induced oxidative stress and DNA oxidative damage. Planta Med. (2004)
  66. Chaudhary A, Singla SK, Tandon C. In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization. Indian J Pharm Sci. (2010)
  67. Manna P, Sinha M, Sil PC. Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Rep. (2008)
  68. Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna–a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine. (2005)
  69. Sun FY, et al. Arjunic acid, a strong free radical scavenger from Terminalia arjuna. Am J Chin Med. (2008)
  70. Reddy TK, et al. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage. Phytother Res. (2008)
  71. Pal S, et al. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. (2011)
  72. Manna P, et al. Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes. Chem Biol Interact. (2007)
  73. Kaur K, et al. Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna. Food Chem Toxicol. (2002)
  74. Gangadevi V, Muthumary J. A novel endophytic Taxol-producing fungus Chaetomella raphigera isolated from a medicinal plant, Terminalia arjuna. Appl Biochem Biotechnol. (2009)
  75. Gangadevi V, Muthumary J. Taxol production by Pestalotiopsis terminaliae, an endophytic fungus of Terminalia arjuna (arjun tree). Biotechnol Appl Biochem. (2009)
  76. Ehrlich ascites carcinoma.
  77. Ramesh AS, et al. Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna. Nat Prod Res. (2012)
  78. Ganesan R, Kamalraj P, Muthuchelian K. Protective effects of ethanolic extract residue isolated from the bark of Terminalia Arjuna against DLA tumour cells. Asian Pac J Cancer Prev. (2010)
  79. Verma N, Vinayak M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol Biol Rep. (2009)
  80. Dhanarasu S, et al. Terminalia Arjuna (Roxb.) Modulates Circulatory Antioxidants on 7,12-dimethylbenz(a)anthracene- induced Hamster Buccal Pouch Carcinogenesis. Oman Med J. (2010)
  81. Kuo PL, et al. Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn. Anticancer Drugs. (2005)
  82. Sivalokanathan S, Vijayababu MR, Balasubramanian MP. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J Gastroenterol. (2006)
  83.  Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem. (2006)
  84. Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Indian J Exp Biol. (2005)